Development and validation of uv spectroscopic method for the estimation of canagliflozin in bulk and tablets
Keywords:
Canagliflozin, UV Spectroscopic method, MethanolAbstract
The present work was aimed to develop and validate an improved UV Spectroscopic method for the determination of Canagliflozin in bulk and tablet dosage forms. The diluent used was Methanol: Distilled water (1:1) and the drug was estimated 224 nm. The developed UV Spectroscopic method for Canagliflozin used Methanol: Distilled water (1:1) as the diluent and estimated at 224 nm. Percent recovery for the drug at 80, 100 and 120 % levels was 99.82-100.09. % RSD for intra-day and inter-day precision were 0.75 and 0.84 respectively. Linearity was observed from 10-60µg/ml with a correlation coefficient of 0.999. LOD and LOQ were 0.33 and 1.00µg/ml respectively. The percentage purity of the drug was found to be 99.79 from the assay results. The method developed was simple, sensitive and cost-effective and could be used for the analysis of the drug in educational institutions.
Downloads
References
International Diabetes Federation (2019): Statistics of Diabetes mellitus retrieved from idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html.
Rang HP, Dale MM, Ritter JM, Flower RJ and Henderson G (2012): Rang and Dale's Pharmacology, Edinburgh, Churchill Livingstone, 7th Edn, pp 377-383.
Katzung BG, Masters SB and Trevor AJ (2015): Basic and Clinical Pharmacology, 13th Edn, New York, McGraw Hill Medical, pp 736-742.
Das, S.K., Elbein S.C., (2006): The Genetic Basis of Type 2 Diabetes. Cell Science: 2(4):p.no.100-131.
Goodman L, Gilman A, Brunton L, and Chabner B, Knollmann B (2011): Goodman and Gilman's the Pharmacological Basis of Therapeutics, 12th Edn: New York, McGraw-Hill, pp 892-1266.
Ralston S, Penman I, Strachan M, Hobson R and Davidson S (2018): Davidson's Principles and Practice of Medicine, 23rd Edn, Edinburgh, Churchill Livingstone/Elsevier, pp 748.
FDA Label: Janssen Pharmaceuticals Inc (2013): INVOKANA (Canagliflozin) tablets, for oral use Initial US Approval, Retrieved from https://www.accessdata. fda.gov/drugsatfda_docs/label/2018/204042s027lbl.pdf.
Martindale: Brayfield A (2014): The Complete Drug Reference, 38th Edn, Pharmaceutical Press: London, UK, 469-1488.
Gorog S (2011): Ultraviolet-visible spectrophotometry in pharmaceutical analysis. CRC press, pp 7-161.
ICH Harmonized Triplicate Guideline (2005): Validation of Analytical Procedures: Text and Methodology Q2 (R1), ICH Steering Committee, Step 4 of ICH process, Retrieved form https://database.ich.org/sites/default/files/Q2_R1__Guideline.pdf.
Drug bank, Canagliflozin: https://www.drugbank.ca/ alts/DBSALT001783
Singh D, Bedi N and Tiwary AK (2019): Comparison of UV Spectrophotometric and HPLC Method for Estimating Canagliflozin in Bulk and Tablet Dosage Form. Indian Journal of Pharmaceutical Sciences, 81(1): 39-44.
Chinta Pooja, Gurdeep Singh, Dharmesh Sisodiya (2018): Development and Validation of UV Spectrophotometric Method for the Estimation of Canagliflozin in Bulk and Pharmaceutical Dosage Form, International Journal of Pharmacy and Pharmaceutical Research humanjournals,13(1): 1-9.
Kaur I, Wakode S and Singh HP (2015): Development and validation of UV spectroscopic method for determination of Canagliflozin in bulk and pharmaceutical dosage form, Pharmaceutical Methods, 6(2): 82-86.
Published
How to Cite
Issue
Section
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright © Author(s) retain the copyright of this article.
